AzTrials
AzTrials

Retinal DiseaseRetine-FochNCT04956237

Retinal Surgery With or Without Anesthesiologist, Comparison of Surgeon and Patient's Comfort

An observational study of Retinal Disease, run by Hopital Foch at 2 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Retinal surgeries are now performed in some hospitals with sub-Tenon anesthesia to replace conventional peribulbar anesthesia. The advantages of performing the surgery with Tenonian anesthesia can be: the cost reduced due to the non-intervention of an anesthesiologist, no pre-operative anesthetic consultation, no… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Retinal Disease
Type of treatment
Injection or infusion
How many people
164 participants
Where
2 sitesFrance
Study dates
9 Sep 2021to 29 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Any patient over 18 years of age undergoing retinal surgery including retinal detachment, epi-retinal membrane-internal limiting peel, macular hole, implant dislocation, vitrectomy, revision of capsular rupture

Who may be able to join

  • Patients over 18 years old
  • Patients with an indication for retinal surgery
  • Not having opposed to participate in the study

Who cannot join

  • Claustrophobia
  • Unbalanced psychiatric pathology
  • Inability to lie down
  • Deprived of liberty or under guardianship.

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Clinique Pierre Cherest

    Neuilly-sur-Seine, 92200

  • Foch Hospital

    Suresnes, 92150

Other trials in France

About this study

Retinal surgeries are now performed in some hospitals with sub-Tenon anesthesia to replace conventional peribulbar anesthesia. The advantages of performing the surgery with Tenonian anesthesia can be: the cost reduced due to the non-intervention of an anesthesiologist, no pre-operative anesthetic consultation, no waiting period for the effectiveness of the peribulbar anesthesia (15-20min to have the effect of anesthesia of the eye). In addition, there are more numerous and dangerous complications of peribulbar anesthesia than sub-Tenonian anesthesia, however it allows the eye to remain stationary and to perform precise surgery safely, as long as the patient does not move his head.

Performing a sub-Tenonian anesthesia also makes it possible to carry out surgeries more quickly, this method having an immediate effect and being performed by the surgeon, without the intervention of an anesthesiologist.

Read more

The edema effect under the post / conjunctiva swells the area around the eye and allows partial oculomotor limitation. Finally, for the patient, recovery is faster: no sedation or venous route.

To date, however, no study has proven that the surgeon can safely operate on the patient without increased complications compared to peribulbar anesthesia.

This study aims to show that simple sub-Tenonian anesthesia in a short outpatient circuit does not induce more pain or discomfort for the patient than a longer outpatient circuit with bed and anesthesiologist. No studies have been performed on purely local anesthesia without a venous route.

For this, patients operated on at the Foch hospital without an anesthesiologist under subtenon's anesthesia will be compared to patients operated on under peribulbar anesthesia with an anesthesiologist at the Pierre Cherest clinic.

Conditions
Retinal Disease
Keywords
Peribulbar surgery, Tenonian surgery, Retinal surgery, Surgeon comfort, Patient comfort
Medical subject headings
Retinal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04956237
Study groupRoleWhat they receive
Tenonian surgeryHospital recruitment with outpatient surgery without the presence of an anesthesiologist, without loco-regional anesthesia and without intravenous route
Peribulbar surgeryGold standard: City recruitment with outpatient surgery with the presence of an anesthesiologist and with loco-regional anesthesia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of the comfort and safety of the surgeon between patients operated with peribulbar or tenonian anesthesia

    Number of eye or head movements of the patient during the operation

    Measured: At the surgery

Secondary outcomes (4)
  1. Comparison of the patient's comfort during the operation between the 2 groups

    Postoperative Iowa Satisfaction with Anesthesia Scale (ISAS) Score rated from 11 (worse outcome) to 66 (better outcome)

    Measured: 15 minutes after the end of the surgery

  2. Comparison of the patient's comfort during the operation between the 2 groups regarding pain

    Visual analogic scale (VAS) of pain during the surgery rated from 0 "No pain" to 10 "worst possible pain"

    Measured: Preoperative, peroperative and 15 minutes post surgery

  3. Comparison of operating time between the 2 groups

    Operating time

    Measured: At the end of the surgery

  4. Assessement of the security between the 2 groups

    Intraoperative complications and peroperative events

    Measured: At the end of the surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2021
  2. Study start9 Sep 2021
  3. Primary completion29 Feb 2024
  4. Study completion29 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
164 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04956237
Sponsor's protocol ID
2020_0138
Acronym
Retine-Foch
Status last verified
Jul 2024
First submitted
30 Jun 2021
Last updated
31 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Retinal Disease, run by Hopital Foch at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of the comfort and safety of the surgeon between patients operated with peribulbar or tenonian anesthesia (time frame: At the surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in